18Sep 2023
ST3G5 Discovery Unveils Potential Cure for Peritoneal Cancer Metastasis

ST3G5 Discovery Unveils Potential Cure for Peritoneal Cancer Metastasis

This study reveals the critical role of lactosylceramide alpha‐2,3‐sialyltransferase (ST3G5) in peritoneal cancer spread. Peritoneal mesothelial cells and immune cells' interactions create a favorable environment for cancer cells to metastasize in the peritoneum. Exosomes from ST3G5high cancer cells containing hypoxia-inducible factor (HIF1α) were discovered to accumulate in peritoneal milky spots (MSs). These exosomes triggered pro-inflammatory responses and mesothelial-mesenchymal transition (MMT) in peritoneal mesothelial cells, aiding metastasis. Additionally, they induced T cell exhaustion. Targeting ST3G5 or using Maraviroc, a CCR5 antagonist, showed promise in preventing peritoneal cancer dissemination.

  • #oncology

Like

Save

Share